Finance
Stocks making the biggest moves midday: Salesforce, Five Below, Okta, Costco and more
Published
1 year agoon
By
New Yorker
Check out the companies making headlines in midday trading.
Salesforce — Shares of the cloud-based software company slid more than 8.3% after the firm announced the sudden departure of co-CEO Bret Taylor. The Dow component dragged down the 30-stock average during Thursday’s sell-off. Salesforce did report earnings and revenue that beat analyst expectations for the most recent quarter, however.
Costco – Shares of retailer Costco shed nearly 6.6% after the company reported softer-than-expected sales figures for November that could signal a weak consumer heading into the holiday shopping season. The company announced that sales in November rose 5.7% to $19.17 billion on the year, less than the growth seen in October and September.
Snowflake — Shares of Snowflake gained more than 7.8% after analysts from Morgan Stanley and MoffettNathanson reiterated their bullish stance on the stock’s long-term prospects. The cloud data platform provider reported earnings that beat expectations but provided light revenue guidance, which sent the stock lower after-hours Wednesday.
Okta — The identity management software provider’s stock surged more than 26% after the company shared a better-than-expected outlook and topped Wall Street’s estimates for the recent period. Analysts had anticipated a loss of 24 cents for the quarter.
Five Below – Shares of the discount retailer jumped 16.6% after Five Below beat estimates on the top and bottom lines for the latest quarter. The company reported 29 cents of earnings per share on $645 million of revenue. Analysts surveyed by Refinitiv were expecting 14 cents of earnings per share and $613 million of revenue. Fourth-quarter guidance also topped expectations. CEO Joel Anderson said in a statement that ticket and transaction metrics improved during the third quarter.
Victoria’s Secret — Shares fell 6.3% after Victoria’s Secret reported mixed results from its most recent quarter. The lingerie company reported earnings of 29 cents per share on revenue of $1.32 billion. Analysts polled by Refinitiv were expecting earnings of 23 cents per share on revenue of $1.33 billion. JPMorgan downgraded the stock to neutral from overweight after the results, citing trouble in the company’s core business.
PVH — Shares surged 9.4% after PVH surpassed Wall Street’s expectations and posted strong quarterly guidance, saying it expects full-year revenues to finish within the higher end of its expected range.
Splunk — Splunk’s stock added 17.8% on solid quarterly results and an upbeat full-year forecast. The company also noted benefits from cost-cutting.
Designer Brands – Shares of the footwear retailer tumbled 25.2% after the company reported quarterly earnings and revenue that missed Wall Street estimates. It also cut its profit outlook, citing the volatile economic environment.
Dollar General – The discount retailer saw its shares drop 7.6% after posting earnings for the latest quarter than fell short of analysts’ expectations by 21 cents per share and lowered its annual forecast due to higher costs.
Aclaris Therapeutics — Shares jumped 4.2% after Goldman Sachs initiated coverage on Aclaris Therapeutics with a buy rating. The firm said the biopharma stock could jump more than 60% on a possible new treatment for immuno-inflammatory diseases.
Nutanix — Nutanix’s stock gained 8.1% amid a Bloomberg report that Hewlett Packard Enterprise has recently held potential takeover talks with the cloud computing company, citing sources familiar with the situation.
Lands’ End — Shares toppled more than 30% after the apparel retailer posted an unexpected loss for the recent quarter and revenue fell short of analysts’ expectations.
Ally Financial — Ally Financial’s stock slipped 4% following a downgrade to underweight by Morgan Stanley, citing a cautious consumer credit outlook ahead.
GoodRx — The stock jumped 18.4% after Citi initiated coverage of the discount drugs app with a buy rating and said the selloff in shares of GoodRx is overdone. The firm’s target suggests potential upside of more than 60%.
— CNBC’s Sarah Min, Tanaya Macheel, Michelle Fox, Jesse Pound, Carmen Reinicke and Yun Li contributed reporting
Source: CNBC
Hero Drives Their Pagani Utopia Through the Flooded Streets of Dubai
Turkish first lady hails doc shedding light on Israeli war crimes
Man dies after setting himself ablaze near Trump trial courthouse
20 Great Deals on Eco-Friendly Products to Celebrate Earth Day
Taylor Swift ‘thanks’ Kim Kardashian on Tortured Poets song as she reflects on feud
Bovine Colostrum Supplements Are Everywhere—But Are the Health Benefits Legit?
You’ll Now Have to Pay Extra for an Actual Color on Your 2024 Mustang
Discover Ubud With Hoshinoya Bali
Aston Martin Reverses Course, Will Sell Combustion Cars Into the 2030s
Improved search drives OTA investment in 2024, finds Amadeus
20 Great Deals on Eco-Friendly Products to Celebrate Earth Day
Why Justin Timberlake Turned Down Working With Jay-Z
South Korean president facing 3 lame duck years? – Asia Times
4/20 grew from humble roots to marijuana’s high holiday
Bitcoin Miners Brace for the ‘Halving’—and Race to Cash In
Trending
-
Tech2 hours ago
Philosopher Daniel Dennett dead at 82
-
News2 hours ago
VW workers in Tennessee vote to join UAW in historic win for Detroit union
-
Tech2 hours ago
Amazon surprises 13 Seattle-area students with ‘Future Engineer’ college scholarships
-
Sport2 hours ago
Hamilton suffers shock early elimination in qualifying for Chinese GP
-
News2 hours ago
Where to find this escargot bagel — for a limited time only
-
News45 mins ago
Pedestrian hit by car near major Tampa intersection
-
Tech2 hours ago
Chucky Fans Now Have to Wait a Week Before Streaming New Episodes on Peacock
-
Auto36 mins ago
Tesla Delivered More Cybertrucks in Four Months Than Hummer EVs Sold Last Year